Skandinaviska Enskilda Banken AB publ Grows Holdings in Alteryx, Inc. (NYSE:AYX)

Posted by Defense World Staff on Feb 25th, 2023

Skandinaviska Enskilda Banken AB publ raised its position in shares of Alteryx, Inc. (NYSE:AYX – Get Rating) by 147.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 985 shares of the company’s stock after purchasing an additional 587 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Alteryx were worth $55,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Ancora Advisors LLC bought a new stake in shares of Alteryx during the 1st quarter valued at $29,000. Ellevest Inc. bought a new stake in Alteryx during the third quarter valued at about $32,000. PNC Financial Services Group Inc. lifted its position in shares of Alteryx by 14.9% in the first quarter. PNC Financial Services Group Inc. now owns 1,583 shares of the company’s stock valued at $114,000 after acquiring an additional 205 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in shares of Alteryx by 10.6% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 2,294 shares of the company’s stock worth $128,000 after acquiring an additional 219 shares during the period. Finally, NuWave Investment Management LLC purchased a new stake in shares of Alteryx during the third quarter worth about $161,000. 74.23% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have weighed in on AYX. Oppenheimer upped their price target on Alteryx from $70.00 to $80.00 and gave the stock an “outperform” rating in a research note on Friday, February 10th. Truist Financial reaffirmed a “buy” rating and set a $80.00 target price on shares of Alteryx in a research note on Friday, November 11th. JMP Securities decreased their price target on shares of Alteryx from $127.00 to $95.00 and set a “market outperform” rating on the stock in a research note on Wednesday, November 2nd. Piper Sandler raised their price objective on Alteryx from $60.00 to $87.00 and gave the company an “overweight” rating in a research report on Friday, February 10th. Finally, Cowen boosted their target price on Alteryx from $75.00 to $85.00 and gave the stock an “outperform” rating in a research report on Friday, February 10th. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $77.54.

Insider Buying and Selling

In other Alteryx news, insider Paula Hansen sold 6,500 shares of the business’s stock in a transaction on Wednesday, November 30th. The shares were sold at an average price of $44.10, for a total transaction of $286,650.00. Following the transaction, the insider now owns 105,793 shares in the company, valued at $4,665,471.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 13.84% of the stock is owned by corporate insiders.

Alteryx Price Performance

Shares of Alteryx stock opened at $66.20 on Friday. The stock has a market cap of $4.60 billion, a price-to-earnings ratio of -14.18 and a beta of 0.51. The company has a debt-to-equity ratio of 4.57, a quick ratio of 1.46 and a current ratio of 1.46. The stock has a 50 day moving average price of $55.45 and a 200-day moving average price of $54.59. Alteryx, Inc. has a one year low of $39.55 and a one year high of $76.35.

About Alteryx

(Get Rating)

Alteryx, Inc engages in the provision of self-service data analytics software. Its subscription-based platform allows organizations to prepare, blend, and analyze data from a multitude of sources and benefit from data-driven decisions. The company was founded by Dean A. Stoecker, Olivia Duane-Adams, and Edward P.